The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
327 - 507 jobs Number of planned job losses
Announcement Date
11 December 2018
Employment effect (start)
1 January 2019
Foreseen end date
30 September 2019
Description
The German pharmaceutical company Boehringer Ingelheim has announced a reorganisation of its activities in France and the loss of 327 jobs. The job cuts will affect the group's two French entities: 130 job cuts by Merial at Lyon (animal health, 2,300 employees) and 197 by BI France at Paris (human health, 500 employees). These job cuts represent 10% of the workforce in France. Management justifies these measures by 'an increasingly restrictive sector, particularly in human health', the need to 'resize the commercial organisation' and its long-standing intention 'to group the group's support functions in Lyon'. The plan also provides for the modification of 180 employment contracts (including 120 for BI France) for medical representatives (changes in geographical areas) and transfers to Lyon. These employees could be dismissed if they refuse their transfer.
The group bought the animal health division (Mérial) from Sanofi Group in January 2017. According to Boehringer Ingelheim, it has invested €335 million in this sector and created 250 jobs. But the end of the two-year employment guarantee period, negotiated at the time of the takeover, is coming to an end and the Lyon site, 'with its duplicates inherited from the merger, is targeted by job groupings', says a union source. Boehringer Ingelheim has 47,000 employees and a turnover of 16 €billion.
Sources
Citation
Eurofound (2018), Boehringer Ingelheim France, Internal restructuring in France, factsheet number 96189, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/96189.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...